scispace - formally typeset
Y

Yi Liu

Researcher at Capital Medical University

Publications -  143
Citations -  8609

Yi Liu is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Mesenchymal stem cell. The author has an hindex of 32, co-authored 90 publications receiving 7112 citations. Previous affiliations of Yi Liu include University of Southern California.

Papers
More filters
Journal ArticleDOI

Mesenchymal Stem Cell-Mediated Functional Tooth Regeneration in Swine

Wataru Sonoyama, +11 more
- 20 Dec 2006 - 
TL;DR: This work transplanted both human SCAP and periodontal ligament stem cells to generate a root/periodontal complex capable of supporting a porcelain crown, resulting in normal tooth function and recovery of tooth strength and appearance.
Journal ArticleDOI

Characterization of the Apical Papilla and Its Residing Stem Cells from Human Immature Permanent Teeth: A Pilot Study

Wataru Sonoyama, +6 more
- 01 Feb 2008 - 
TL;DR: The apical papilla is distinctive to the pulp in terms of containing less cellular and vascular components than those in the pulp, and both SCAP and DPSCs were as potent in osteo/dentinogenic differentiation as MSCs from bone marrows, whereas they were weaker in adipogenic potential.
Journal ArticleDOI

The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering.

George T.-J. Huang, +5 more
- 01 Jun 2008 - 
TL;DR: The potential role of mesenchymal stem cells in the following respects will be discussed: their contribution in continued root maturation in endodontically treated immature teeth with periradicular periodontitis or abscess and their potential utilization for pulp/dentin regeneration and bioroot engineering.
Journal ArticleDOI

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis

Qunzhou Zhang, +6 more
- 15 Dec 2009 - 
TL;DR: Takeaway is that gingiva-derived mesenchymal stem cells can function as an immunomodulatory and anti-inflammatory component of the immune system in vivo and is a promising cell source for cell-based treatment in experimental inflammatory diseases.
Journal ArticleDOI

Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α

Yi Liu, +10 more
- 01 Dec 2011 - 
TL;DR: It is shown that proinflammatory T cells inhibit the ability of exogenously added bone marrow mesenchymal stem cells (BMMSCs) to mediate bone repair, and a previously unrecognized role of recipient T cells in BMMSC-based tissue engineering is shown.